- The immune system's ability to police itself may offer a new method of
arresting the cells responsible for autoimmune diseases such as multiple
sclerosis and for the rejection of transplanted organs and tissues,
scientists at Dana-Farber report in a study in the May issue of the
- Susan G. Komen for the Cure, the world's largest grassroots network of
breast cancer survivors and activists, has announced the appointment of
Eric P. Winer, MD, a nationally known medical oncologist, researcher
and educator from the Dana-Farber Cancer Institute and Harvard Medical
Center, as its chief scientific advisor.
- A team led by Dana-Farber scientists has developed a more human-like
mouse model of cancer they say will aid the search for cancer-causing
genes and improve the predictive value of laboratory drug testing.
Tags: Genomics, Genetics
- Blacks in the United States are less certain than whites about recommendations to prevent lung cancer and are more fearful of having symptoms evaluated — beliefs that may keep them from seeking timely treatment for the disease, researchers from Dana-Farber Cancer Institute reported at the American Society of Clinical Oncology's annual meeting in Chicago.
Tags: LungCancer, Disparities
- Normally sedentary breast cancer survivors who completed an exercise
program reduced the levels of insulin in their blood, revealing a likely
link between physical activity and better outcomes, researchers from
Dana-Farber Cancer Institute in Boston reported at the annual meeting of
the American Society of Clinical Oncology in Chicago.
Tags: BreastCancer, Exercise
- The drug lapatinib shrank tumors and slowed progression of brain
metastases in some patients with advanced breast cancer, according to
results of a clinical trial being presented by Dana-Farber Cancer
Institute scientists at the annual meeting of the American Society of
- Physicians who inform parents of children with cancer about the likely
course of the disease can provide hope, even when the child's prognosis
is poor, according to a Dana-Farber Cancer Institute study presented at a
press briefing at the American Society of Clinical Oncology annual
- Patients with stage III colon cancer who have undergone surgery and
chemotherapy with the goal of cure may have a higher risk of relapsing
and dying early if they follow a predominantly "Western" diet of red
meat, fatty foods, refined grains, and desserts, according to research
led by investigators at Dana-Farber Cancer Institute in Boston.
- Using a novel three-part screening process, scientists at Dana-Farber
Cancer Institute have identified a gene that is made inappropriately in
about a third of all breast cancers. The discovery, reached in
collaboration with researchers at Brigham and Womens Hospital (BWH) and
the Broad Institute of Harvard and MIT, is reported in the June 15,
2007, issue of the journal Cell.
Tags: BasicResearch, BreastCancer
- Dana-Farber Cancer Institute today celebrated the ceremonial
groundbreaking for the Yawkey Center for Cancer Care, a state-of-the-art
outpatient care and clinical research facility that will serve as the
model for cancer centers of the future.
Showing 21-30 of 484 items